Editorial discusses phage therapy's potential to combat antibiotic resistance at the 2025 phage conference, suggesting future implications.
This editorial provides a brief background on over a century of research on bacteriophages, which led to the inaugural 2025 Conference on Bacteriophages: Biology, Dynamics, and Therapeutics, supported by the IAS–USA. A summary of this meeting is included in this issue of Pathogens and Immunity and emphasizes the promise of phage therapy.
No takes yet. Share an insight, caveat, or question.
Lederman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: